BAFNAPH — BAFNA Pharmaceuticals Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousMicro CapNeutral

Annual balance sheet for BAFNA Pharmaceuticals, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	2021 March 31st	R2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	PRESS
Standards:	IAS	IAS	IAS	IAS	—
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	18	1.73	78.1	21	34.3
Net Total Accounts Receivable
Net Total Receivables	95.6	155	559	615	405
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	497	509	873	945	847
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	368	388	402	507	661
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	865	901	1,296	1,477	1,531
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	243	220	465	541	519
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Funded Status
Total Liabilities	297	282	561	668	683
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Total Equity	568	620	735	808	848
Total Liabilities & Shareholders' Equity	865	901	1,296	1,477	1,531
Total Common Shares Outstanding